未登录

徐广超 (Guangchao Xu)

zunyi medical university副研究员

H指数:17

被引数:1,087

个人简介

副研究员。博士毕业于四川大学，2015-2017年通过国家公派于美国麻省大学医学院联合培养博士18个月。2019年7月进入遵义医科大学附属医院烧伤整形外科，主要从事皮肤肿瘤发生和皮肤组织损伤修复的研究工作。已发表SCI论文25篇，相关论文发表在Journal of Investigative Dermatology、Advanced Functional Materials等期刊。

教育背景

2015.01 – 至今
美国麻省大学医学院联合培养博士

工作经历

2019.07 – 至今
遵义医科大学附属医院烧伤整形外科
副研究员

荣誉奖项

暂无内容

FLIM Reveals Red Light-Induced Changes in Murine Hair Follicles

FLIM揭示红光诱导的小鼠毛囊变化

IF5.6

2026-04-230

OA

Transcriptome profile of keloid patients in Zunyi, China via multiple bioinformatic analyses

中国遵义地区瘢痕疙瘩患者转录组特征的多重生物信息学分析

IF2.9

2026-04-220

PREAI

T-cell mesenchymal transition represents a potential pathogenic mechanism of female cancer-related lymphedema

T细胞间质转化是女性癌症相关淋巴水肿的潜在致病机制

Nature Communications

IF15.7

2026-04-200

OAAI

Personalized human umbilical cord mesenchymal stem cell-derived exosome pre-treatment based on the simulation of scar microenvironment characteristics: a promising approach for early scar treatment

基于瘢痕微环境特征模拟的个性化人脐带间充质干细胞来源外泌体预处理：一种早期瘢痕治疗的可行方法

Molecular Biology Reports

IF2.8

2025-07-230

PRE

Targeting the MAPK pathway for NRAS mutant melanoma: from mechanism to clinic

针对NRAS突变黑色素瘤的MAPK通路靶向治疗：从机制到临床

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2025-06-016

PRE

eIF6 modulates skin wound healing by upregulating keratin 6B

STEM CELLS TRANSLATIONAL MEDICINE

IF4.9

2024-10-150

OAAI

Metformin Eliminates Lymphedema in Mice by Alleviating Inflammation and Fibrosis: Implications for Human Therapy

PLASTIC AND RECONSTRUCTIVE SURGERY

IF3.4

2024-02-222

OAAI

Neural grafts containing exosomes derived from Schwann cell-like cells promote peripheral nerve regeneration in rats

含雪旺细胞样细胞外泌体的神经移植物促进大鼠周围神经再生

IF9.6

2023-04-2722

OA

Inflammatory Microenvironment of Skin Wounds

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-03-0189

OAAI

Single-cell transcriptomic profiling unravels the adenoma-initiation role of protein tyrosine kinases during colorectal tumorigenesis

Signal Transduction and Targeted Therapy

IF52.7

2022-02-280

OAAI

The Evolution of Acquired Resistance to BRAFV600E kinase inhibitor Is Sustained by IGF1-Driven Tumor Vascular Remodeling

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2022-02-0116

OAAI

In situ scarless skin healing of a severe human burn wound induced by a hCTLA4Ig gene-transferred porcine skin graft

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES

IF3.2

2022-01-012

OAAI

Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer

IF7.3

2021-10-3047

OAAI

Editorial: The Prevalence of MDR Non-Fermenting Gram Negative Bacteria and Their Chemotherapy

FRONTIERS IN MICROBIOLOGY

IF4.5

2021-07-282

OAAI

The progress, prospects, and challenges of the use of non-coding RNA for diabetic wounds

MOLECULAR THERAPY-NUCLEIC ACIDS

IF0

2021-06-0125

OAAI

Large-scale molecular epidemiological analysis of AAV in a cancer patient population

IF7.3

2021-03-299

OAAI

Integrin-Src-YAP1 signaling mediates the melanoma acquired resistance to MAPK and PI3K/mTOR dual targeted therapy

Integrin-Src-YAP1信号介导黑色素瘤对MAPK和PI3K/mTOR双靶向治疗的获得性耐药

MOLECULAR BIOMEDICINE

IF10.1

2020-11-1022

OAAI

A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts (vol 5, 14421, 2015)

SCIENTIFIC REPORTS

IF3.9

2020-09-212

OAAI

Structural characterization of a novel human adeno-associated virus capsid with neurotropic properties

NATURE COMMUNICATIONS

IF15.7

2020-06-3043

OAAI

Circumventing cellular immunity by miR142-mediated regulation sufficiently supports rAAV-delivered OVA expression without activating humoral immunity

IF6.1

2019-07-1137

OA